Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Nvidia’s RTX 30 Launch Is a Positive Game-Changer

By Chris Lau, InvestorPlace Contributor

NVDA stock will benefit from the game-changing refresh of the GeForce, with the RTX 30 product release, despite the recent pull-back.

Plug Power Is in the Driver’s Seat as Hydrogen Use Grows

By Chris Lau, InvestorPlace Contributor

Mega deals for Plug Power from companies like Walmart and Home Depot are set to lift PLUG stock further.

What Happens Next After Workhorse’s Spectacular Run-up

By Chris Lau, InvestorPlace Contributor

Bears are wrong in their big bet against WKHS stock, as a huge influx in Ryder orders is set to boost revenue.

When It Comes to Novavax Stock, It’s All About Clinical Results

By Chris Lau, InvestorPlace Contributor

Novavax had a good run in the last few months and after the August drop, investors will look forward to the clinical study numbers

Why the New F-150 Could Move the Needle for Ford

By Chris Lau, InvestorPlace Contributor

F stock will likely continue to rebound as the company is preparing to release multiple promising vehicles.

Load More